Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
The DENV-2 variant has caused a rapid surge in dengue fever and death cases in Panchkula, Haryana
Israel and Argentina will jointly sponsor five research projects in the fields of medicine and green energy, Israel's Ministry of Innovation, Science and Technology said in a statement
Adar Poonawalla has taken Indian vaccines to the US and European markets. In an interview with Business Standard's Sohini Das, he tells about his plans for mass production of vaccines and more
AAP leader Sanjay Singh has complained to police against an Uttar Pradesh minister and some senior officials, alleging corruption in the purchase of medical equipment
Govt officials say health outlay will have to rise significantly not just for vaccine expense but also for creation of supporting infra and distribution channels
The platform runs on a software called Power BI, a data visualisation tool that evaluates the vitals of all patients in ICUs in over 15 districts of Karntaka
Medtronic Engineering and Innovation Center (MEIC) will be its largest global research and development center outside the US, it said in a statement
Convalescent plasma is an experimental procedure for coronavirus patients
Projected to cost less than Rs 50,000 apiece on mass production
Putting aside prices for a moment, it's been an exciting period for medical progress
The emergency preservation and resuscitation procedure has already been used on at least one patient to give doctors more time
Panagariya said there was a huge scope for India to improve medical treatment
Panagariya said India's health sector is still very much evolving and very informal
The country has one government doctor for 11,000 people. The WHO recommends one doctor for 1,000 people. The situation is worse in rural India where a government doctor serves over 30,000 people
The firm is also trying to create a start-up ecosystem to collaborate with healthcare start-ups and commercialise their ideas in the India market
It holds the potential to change the therapeutic landscape for many neurological and non-neurological conditions in future
The company aims to conduct laboratory grade diagnostic tests related to non-communicable diseases on a single device connected to the mobile phone
A study, published in the journal Nature Communications, outlines a layer-by-layer printing method that features fine-grain, programmable control over rigidity
Medical technology start-ups are beginning to shift to a pay-per-use model for their diagnostic devices as they look to gain acceptance in a crowded Indian market.These start-ups have been able to convert hospitals and clinicians into customers with the lure of not having to make a large initial investment to buy the device, but only smaller monthly payments. Several med-tech start-ups are now switching to a pay-per-use model, with TRICOG, Cyclops and BPL being among those that have seen some initial success.While Bengaluru-based Cyclops' device that can diagnose vertigo based on eye expression costs half as much as imported devices, the company found more takers for its subscription model. Also, since the data collected through tests were now accessible to Cyclops, it is now focusing on early detection rather than diagnosis."For a start-up to offer a pay-per-use model, the advantage is that the access to the data remains with the company. When I have all the data, it is much easier to
While pre-owned equipment can work for 7-10 years, the environmental regulations in India makes it difficult to import, says industry body